New Market Study: "Adaptive Biotechnologies Corporation - Product Pipeline Analysis."
Adaptive Biotechnologies Corporation(Adaptive), formerly known as Adaptive TCR Corporation, develops sequencing assays for the adaptive immune system. With the help of its patent-pending technology, the company is able to identify the exact makeup of approximately 10-15 million unique TCRs in one individual as compared to previous techniques that could make up only about 30,000. The company offers research and diagnostic tools for scientists, doctors, and clinicians. It offers immunoSEQ, a suite of immune profiling assays coupled with cloud-based analyzation software...
View full press release